This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

ONLINE REGISTRATION CLOSES IN:

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San Diego

Katherine Harris, PhD
Vice President, Discovery at Amgen

Profile

Dr. Katherine Harris is currently the Vice President of Discovery at Teneobio, a multi-specific biotherapeutic antibody company redirecting the immune system to fight cancer.  She joined Teneobio when the company started lab operations in 2015, playing a key role in both building and managing a high-throughput antibody discovery platform.  Prior to her work at Teneobio, she was a research scientist at Active Motif and SwitchGear Genomics where she focused her efforts on developing a functional genomics platform for small molecule screening.  Katherine holds a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley.

Agenda Sessions

  • Co-Chairs’ Remarks

    2:25pm
  • A Bispecific Antibody Agonist of The IL-2 Heterodimeric Receptor Promotes In Vivo Expansion Of CD8 And NK Cells

    11:30am